Quarterly Report 30 September 2008 30 April 201331 October 2008 by Karen Mobbs Quarterly Report 30 September 2008
Presentation to Annual General Meeting 4 March 201413 October 2008 by Karen Mobbs Presentation to Annual General Meeting
Resolutions Passed at Annual General Meeting 30 April 201313 October 2008 by Karen Mobbs Resolutions Passed at Annual General Meeting
Annual Report for year ended 30 June 2008 and Notice of Annual General Meeting 30 April 201315 September 2008 by Karen Mobbs Annual Report for year ended 30 June 2008 and Notice of Annual General Meeting
BIT225 Highly Synergistic with New Class of Anti-HCV Therapies 30 April 20139 September 2008 by Karen Mobbs BIT225 Highly Synergistic with New Class of Anti-HCV Therapies
Year End Accounts and Preliminary Final Report for year ended 30 June 2008 30 April 201329 August 2008 by Karen Mobbs Year End Accounts and Preliminary Final Report for year ended 30 June 2008
Biotron Expands HCV Clinical Trial to a Second Site 30 April 201314 August 2008 by Karen Mobbs Biotron Expands HCV Clinical Trial to a Second Site
Phase Ib/IIa HCV Clinical Trial Commenced 30 April 20137 August 2008 by Karen Mobbs Phase Ib/IIa HCV Clinical Trial Commenced
